Julian Baker’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Julian Baker’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-807,212	Closed	-$9.92M	–	117
2022 Q4	$9.92M	Hold	807,212	–	–	0.06%	58
2022 Q3	$26.5M	Buy	+807,212	New	+$22.8M	0.17%	38

Julian Baker's CINC Position: Q1 2023 in Review

Julian Baker sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 807,212 shares — an estimated $9.92M sold.

Julian Baker first reported a position in CINC in Q3 2022 and held it in 2 quarters. The position peaked at $26.5M in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Julian Baker reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Julian Baker sold 807,212 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $9.92M.
Julian Baker first reported a position in CinCor Pharma, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
Julian Baker's CinCor Pharma, Inc. Common Stock position peaked at $26.5M in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Baker Bros. Advisors's 13F filing for Q1 2023, filed 15 May 2023.